# Peter Kolchinsky portfolio: RA Capital Management 13F (Q2 2026)

URL: https://funkfolio.com/gurus/peter-kolchinsky

> Peter Kolchinsky's Q2 2026 13F: RA Capital Management reported $11.5B in 84 positions. Top holdings: ASND, PBLS, RYTM and PCVX. Latest buys: PBLS and COAG.

---

## Peter Kolchinsky portfolio

RA Capital Management · Biotechnology specialist

RA Capital Management's 13F filing for Q2 2026, filed with the SEC on August 14, 2026, reports $11.5B across 84 US-listed positions. The largest holding is ASND at 23.8% of the portfolio; the ten largest make up 60%. The largest buy last quarter was PBLS, a new position ($791.9M).

**Reported value:** $11.5B

**Positions:** 84

**In the top 10:** 60%

**Quarter:** Q2 2026 filed Aug 14

### Key facts

- **13F portfolio value:** $11.5B Q2 2026
- **Positions:** 84
- **Largest holding:** ASND 23.8%
- **Top 10 share:** 60%
- **New positions:** 16 since Q1 2026
- **Sold out:** 17
- **Filed:** Aug 14, 2026
- **Next 13F due:** Nov 16, 2026 Q3 2026

Holdings as of Jun 30, 2026 (Q2 2026), filed with the SEC on Aug 14, 2026. Changes are measured against the filing for Mar 31, 2026. Source: SEC EDGAR, Form 13F-HR of RA Capital Management (CIK 1346824).

Prices as of 18 Nov 2026, 00:32 UTC.

Compared with Q1 2026, Peter Kolchinsky opened 16 new positions (PBLS, COAG, ABVX…), added to 10, trimmed 10, sold out of 17 (DNTH, PRAX, SRPT…).

By sector, Health Care is the largest at 43% of the reported portfolio, followed by Technology at 0%; 57% is in securities with no sector on file.

26 of the 84 positions listed have been in every one of the last 9 quarterly filings.

### Peter Kolchinsky top holdings: stocks in the Q2 2026 13F

Peter Kolchinsky holdings, Q2 2026

| # | Stock | Sector | Share of portfolio | Value | Shares | Reported price | Price now | Since period end | Held | Last quarter |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1 | [Ascendis Pharma A/S ASND](https://funkfolio.com/stock/ASND) | [Health Care](https://funkfolio.com/companies?sector=health-care) | 23.8% | $2.7B | 10.28M | $266.72 | $271.19 | 1.7% up | 9+ qtrs | — |
| 2 | [Parabilis Medicines Inc PBLS](https://funkfolio.com/stock/PBLS) | — | 6.88% | $791.9M | 28.93M | $27.37 | $28.25 | 3.2% up | 1 qtr | New |
| 3 | [Rhythm Pharmaceuticals Inc RYTM](https://funkfolio.com/stock/RYTM) | [Health Care](https://funkfolio.com/companies?sector=health-care) | 6.43% | $740.2M | 6.67M | $111.03 | $116.61 | 5.0% up | 9+ qtrs | No change |
| 4 | [Vaxcyte Inc PCVX](https://funkfolio.com/stock/PCVX) | [Health Care](https://funkfolio.com/companies?sector=health-care) | 5.80% | $667M | 11.47M | $58.13 | $59.40 | 2.2% up | 9+ qtrs | No change |
| 5 | [Sionna Therapeutics Inc SION](https://funkfolio.com/stock/SION) | — | 3.79% | $435.7M | 9.91M | $43.99 | $3.07 | 93.0% down | 6 qtrs | No change |
| 6 | [Tyra Biosciences Inc TYRA](https://funkfolio.com/stock/TYRA) | — | 3.39% | $389.6M | 12.2M | $31.94 | $19.57 | 38.7% down | 9+ qtrs | No change |
| 7 | [Edgewise Therapeutics Inc EWTX](https://funkfolio.com/stock/EWTX) | [Health Care](https://funkfolio.com/companies?sector=health-care) | 2.96% | $341M | 8.39M | $40.63 | $42.04 | 3.5% up | 9+ qtrs | ▼ Reduced 20% |
| 8 | [Newamsterdam Pharma Company NAMS](https://funkfolio.com/stock/NAMS) | — | 2.81% | $323.7M | 9.55M | $33.89 | $19.39 | 42.8% down | 9+ qtrs | No change |
| 9 | [Hemab Therapeutics Holdings COAG](https://funkfolio.com/stock/COAG) | — | 2.49% | $286.8M | 7.81M | $36.73 | $39.06 | 6.3% up | 1 qtr | New |
| 10 | [Septerna Inc SEPN](https://funkfolio.com/stock/SEPN) | — | 2.04% | $234.3M | 7M | $33.49 | $40.02 | 19.5% up | 7 qtrs | No change |
| 11 | [Bicara Therapeutics Inc BCAX](https://funkfolio.com/stock/BCAX) | — | 1.87% | $215.4M | 7.26M | $29.69 | $9.60 | 67.7% down | 8 qtrs | No change |
| 12 | [Mineralys Therapeutics Inc MLYS](https://funkfolio.com/stock/MLYS) | — | 1.80% | $207.6M | 7.69M | $26.98 | $14.48 | 46.3% down | 9+ qtrs | No change |
| 13 | [GH Research PLC GHRS](https://funkfolio.com/stock/GHRS) | — | 1.78% | $205.3M | 7.64M | $26.88 | $18.27 | 32.0% down | 9+ qtrs | ▼ Reduced 0.5% |
| 14 | [Disc Medicine Inc IRON](https://funkfolio.com/stock/IRON) | — | 1.56% | $179.2M | 2.45M | $73.14 | $76.57 | 4.7% up | 6 qtrs | No change |
| 15 | [Spyglass Pharma Inc SGP](https://funkfolio.com/stock/SGP) | — | 1.55% | $178.6M | 8.02M | $22.26 | $31.44 | 41.2% up | 2 qtrs | No change |
| 16 | [Artiva Biotherapeutics Inc ARTV](https://funkfolio.com/stock/ARTV) | — | 1.51% | $174.2M | 17.96M | $9.70 | $3.86 | 60.2% down | 8 qtrs | ▲ Added 82% |
| 17 | [Janux Therapeutics Inc JANX](https://funkfolio.com/stock/JANX) | — | 1.49% | $171.9M | 11.19M | $15.36 | $10.71 | 30.3% down | 9+ qtrs | No change |
| 18 | [Taysha Gene Therapies Inc TSHA](https://funkfolio.com/stock/TSHA) | — | 1.39% | $160.4M | 23.56M | $6.81 | $4.00 | 41.3% down | 9+ qtrs | No change |
| 19 | [BioCryst Pharmaceuticals Inc BCRX](https://funkfolio.com/stock/BCRX) | — | 1.38% | $158.3M | 15.83M | $10.00 | $7.50 | 25.0% down | 3 qtrs | No change |
| 20 | [Wave Life Sciences Ltd WVE](https://funkfolio.com/stock/WVE) | — | 1.36% | $156.7M | 26.98M | $5.81 | $2.84 | 51.1% down | 9+ qtrs | No change |
| 21 | Nuvalent Inc no ticker on file | — | 1.34% | $153.9M | 1.25M | $123.50 | — | — | 4 qtrs | ▼ Reduced 51% |
| 22 | [Abivax SA ABVX · ADR](https://funkfolio.com/stock/ABVX) | [Health Care](https://funkfolio.com/companies?sector=health-care) | 1.31% | $150.9M | 1.13M | $133.26 | $82.10 | 38.4% down | 1 qtr | New |
| 23 | [Oruka Therapeutics Inc ORKA](https://funkfolio.com/stock/ORKA) | [Health Care](https://funkfolio.com/companies?sector=health-care) | 1.29% | $148M | 1.55M | $95.17 | $96.32 | 1.2% up | 1 qtr | New |
| 24 | [Climb Bio Inc CLYM](https://funkfolio.com/stock/CLYM) | — | 1.28% | $147.4M | 11.3M | $13.04 | $9.78 | 25.0% down | 9+ qtrs | No change |
| 25 | [Solid Biosciences Inc SLDB](https://funkfolio.com/stock/SLDB) | — | 1.05% | $120.2M | 12.04M | $9.99 | $6.23 | 37.6% down | 9+ qtrs | ▲ Added 29% |
| 26 | [Zai Lab Ltd ZLAB · ADR](https://funkfolio.com/stock/ZLAB) | — | 0.95% | $109.1M | 5.74M | $19.00 | $23.53 | 23.8% up | 2 qtrs | ▲ Added 0.6% |
| 27 | [Ars Pharmaceuticals Inc SPRY](https://funkfolio.com/stock/SPRY) | — | 0.76% | $87M | 10.86M | $8.01 | $3.65 | 54.4% down | 9+ qtrs | No change |
| 28 | [Xencor Inc XNCR](https://funkfolio.com/stock/XNCR) | — | 0.74% | $84.9M | 5.27M | $16.10 | $34.50 | 114.3% up | 2 qtrs | ▲ Added 7.7% |
| 29 | [Jade Biosciences Inc JBIO](https://funkfolio.com/stock/JBIO) | — | 0.71% | $81.6M | 3.67M | $22.22 | $15.40 | 30.7% down | 5 qtrs | No change |
| 30 | [Intellia Therapeutics Inc NTLA](https://funkfolio.com/stock/NTLA) | — | 0.67% | $76.6M | 4.53M | $16.92 | $9.78 | 42.2% down | 1 qtr | New |
| 31 | [LB Pharmaceuticals Inc LBRX](https://funkfolio.com/stock/LBRX) | — | 0.62% | $71.7M | 2.21M | $32.46 | $40.30 | 24.2% up | 4 qtrs | No change |
| 32 | [Definium Therapeutics Inc DFTX](https://funkfolio.com/stock/DFTX) | [Health Care](https://funkfolio.com/companies?sector=health-care) | 0.61% | $70.6M | 1.5M | $47.04 | $29.38 | 37.5% down | 1 qtr | New |
| 33 | [Aclaris Therapeutics Inc ACRS](https://funkfolio.com/stock/ACRS) | — | 0.59% | $67.3M | 12.72M | $5.29 | $3.38 | 36.1% down | 2 qtrs | ▲ Added 87% |
| 34 | [4D Molecular Therapeutics FDMT](https://funkfolio.com/stock/FDMT) | — | 0.58% | $67.2M | 5.05M | $13.30 | $10.79 | 18.9% down | 9+ qtrs | No change |
| 35 | [Sana Biotechnology Inc SANA](https://funkfolio.com/stock/SANA) | — | 0.57% | $65.4M | 18.75M | $3.49 | $1.88 | 46.1% down | 1 qtr | New |
| 36 | [Damora Therapeutics Inc DMRA](https://funkfolio.com/stock/DMRA) | — | 0.54% | $62.4M | 2.4M | $26.01 | $22.56 | 13.3% down | 2 qtrs | ▲ Added 0.02% |
| 37 | [Monopar Therapeutics Inc MNPR](https://funkfolio.com/stock/MNPR) | — | 0.54% | $61.8M | 667.21K | $92.59 | $71.06 | 23.3% down | 7 qtrs | No change |
| 38 | [Acumen Pharmaceuticals Inc ABOS](https://funkfolio.com/stock/ABOS) | — | 0.49% | $56.1M | 20.99M | $2.67 | $0.2301 | 91.4% down | 9+ qtrs | No change |
| 39 | [Geron Corp GERN](https://funkfolio.com/stock/GERN) | — | 0.48% | $54.8M | 42.81M | $1.28 | $1.00 | 21.9% down | 9+ qtrs | ▼ Reduced 33% |
| 40 | [Rezolute Inc RZLT](https://funkfolio.com/stock/RZLT) | — | 0.43% | $49.1M | 9.45M | $5.20 | $4.02 | 22.8% down | 3 qtrs | ▲ Added 2.9% |
| 41 | [Evommune Inc EVMN](https://funkfolio.com/stock/EVMN) | — | 0.40% | $46.4M | 3.49M | $13.29 | $7.02 | 47.2% down | 3 qtrs | No change |
| 42 | [Vor Biopharma Inc VOR](https://funkfolio.com/stock/VOR) | — | 0.38% | $44.2M | 2.4M | $18.41 | $18.18 | 1.2% down | 9+ qtrs | ▼ Reduced 56% |
| 43 | [Century Therapeutics Inc IPSC](https://funkfolio.com/stock/IPSC) | — | 0.38% | $43.5M | 17.75M | $2.45 | $1.37 | 44.1% down | 2 qtrs | No change |
| 44 | [Aktis Oncology Inc AKTS](https://funkfolio.com/stock/AKTS) | — | 0.37% | $42.4M | 1.31M | $32.23 | $16.31 | 49.4% down | 2 qtrs | ▼ Reduced 13% |
| 45 | [Bioage Labs Inc BIOA](https://funkfolio.com/stock/BIOA) | — | 0.36% | $41M | 1.67M | $24.51 | $5.10 | 79.2% down | 2 qtrs | ▲ Added 1.3% |
| 46 | [C4 Therapeutics Inc CCCC](https://funkfolio.com/stock/CCCC) | — | 0.33% | $37.4M | 8M | $4.67 | $2.53 | 45.8% down | 3 qtrs | No change |
| 47 | [Mirum Pharmaceuticals Inc MIRM](https://funkfolio.com/stock/MIRM) | [Health Care](https://funkfolio.com/companies?sector=health-care) | 0.32% | $37.3M | 318.55K | $117.07 | $91.95 | 21.5% down | 2 qtrs | No change |
| 48 | [Capricor Therapeutics Inc CAPR](https://funkfolio.com/stock/CAPR) | — | 0.32% | $36.3M | 1.51M | $24.08 | $8.41 | 65.1% down | 3 qtrs | No change |
| 49 | [Pepgen Inc PEPG](https://funkfolio.com/stock/PEPG) | — | 0.31% | $36.1M | 20.06M | $1.80 | $3.88 | 115.6% up | 9+ qtrs | No change |
| 50 | [Prelude Therapeutics Inc PRLD](https://funkfolio.com/stock/PRLD) | — | 0.30% | $34.5M | 6.48M | $5.33 | $3.32 | 37.7% down | 1 qtr | New |
| 51 | [Nkarta Inc NKTX](https://funkfolio.com/stock/NKTX) | — | 0.27% | $30.6M | 10.81M | $2.83 | $1.25 | 55.8% down | 9+ qtrs | No change |
| 52 | [Q32 Bio Inc QTTB](https://funkfolio.com/stock/QTTB) | — | 0.26% | $29.7M | 2.33M | $12.74 | $8.63 | 32.3% down | 1 qtr | New |
| 53 | [Anteris Technologies Global AVR](https://funkfolio.com/stock/AVR) | — | 0.26% | $29.6M | 3M | $9.85 | $5.32 | 46.0% down | 2 qtrs | No change |
| 54 | [Editas Medicine Inc EDIT](https://funkfolio.com/stock/EDIT) | — | 0.25% | $28.8M | 8.89M | $3.24 | $1.83 | 43.7% down | 1 qtr | New |
| 55 | [Ovid Therapeutics Inc OVID](https://funkfolio.com/stock/OVID) | — | 0.25% | $28.2M | 10.5M | $2.69 | $2.22 | 17.5% down | 3 qtrs | ▼ Reduced 2.0% |
| 56 | [Assembly Biosciences Inc ASMB](https://funkfolio.com/stock/ASMB) | — | 0.24% | $28M | 1.02M | $27.48 | $22.50 | 18.1% down | 4 qtrs | No change |
| 57 | [Alx Oncology Holdings Inc ALXO](https://funkfolio.com/stock/ALXO) | — | 0.23% | $26.9M | 13.01M | $2.07 | $1.01 | 51.4% down | 2 qtrs | No change |
| 58 | [Benitec Biopharma Inc BNTC](https://funkfolio.com/stock/BNTC) | — | 0.22% | $24.8M | 1.85M | $13.38 | $8.15 | 39.1% down | 3 qtrs | No change |
| 59 | [Lenz Therapeutics Inc LENZ](https://funkfolio.com/stock/LENZ) | — | 0.21% | $23.7M | 4.18M | $5.68 | $3.50 | 38.4% down | 9+ qtrs | No change |
| 60 | [Lexeo Therapeutics Inc LXEO](https://funkfolio.com/stock/LXEO) | — | 0.20% | $23.3M | 5M | $4.66 | $2.86 | 38.7% down | 3 qtrs | No change |
| 61 | [Acrivon Therapeutics Inc ACRV](https://funkfolio.com/stock/ACRV) | — | 0.19% | $21.8M | 12.23M | $1.78 | $1.43 | 19.7% down | 9+ qtrs | ▲ Added 47% |
| 62 | [Altimmune Inc ALT](https://funkfolio.com/stock/ALT) | — | 0.17% | $19.8M | 6.5M | $3.04 | $1.53 | 49.7% down | 1 qtr | New |
| 63 | [Karyopharm Therapeutics Inc KPTI](https://funkfolio.com/stock/KPTI) | — | 0.16% | $18.7M | 1.92M | $9.77 | $0.0174 | 99.8% down | 2 qtrs | No change |
| 64 | [Bright Minds Biosciences Inc DRUG](https://funkfolio.com/stock/DRUG) | — | 0.16% | $18.6M | 265K | $70.20 | $20.51 | 70.8% down | 2 qtrs | No change |
| 65 | [Avalo Therapeutics Inc AVTX](https://funkfolio.com/stock/AVTX) | — | 0.16% | $18.5M | 1M | $18.48 | $7.13 | 61.4% down | 8 qtrs | ▲ Added 51% |
| 66 | [Onkure Therapeutics Inc-A OKUR](https://funkfolio.com/stock/OKUR) | — | 0.16% | $18.2M | 4M | $4.56 | $2.58 | 43.4% down | 2 qtrs | No change |
| 67 | [Faeth Therapeutics Inc FTH](https://funkfolio.com/stock/FTH) | — | 0.16% | $18.1M | 722.02K | $25.00 | $9.04 | 63.8% down | 1 qtr | New |
| 68 | [Aura Biosciences Inc AURA](https://funkfolio.com/stock/AURA) | — | 0.15% | $17.8M | 2.5M | $7.10 | $7.15 | 0.7% up | 1 qtr | New |
| 69 | [Sab Biotherapeutics Inc SABS](https://funkfolio.com/stock/SABS) | — | 0.15% | $17.2M | 4.4M | $3.90 | $2.95 | 24.4% down | 4 qtrs | No change |
| 70 | [Seaport Therapeutics Inc SPTX](https://funkfolio.com/stock/SPTX) | — | 0.13% | $15.2M | 700K | $21.72 | $18.17 | 16.3% down | 1 qtr | New |
| 71 | [Palisade Bio Inc PALI](https://funkfolio.com/stock/PALI) | — | 0.13% | $14.9M | 7.12M | $2.09 | $1.01 | 51.7% down | 3 qtrs | No change |
| 72 | [Helix Acquisition Corp HLXC](https://funkfolio.com/stock/HLXC) | — | 0.12% | $13.3M | 1.25M | $10.64 | $10.28 | 3.4% down | 2 qtrs | No change |
| 73 | [Waystar Holding Corp WAY](https://funkfolio.com/stock/WAY) | [Technology](https://funkfolio.com/companies?sector=technology) | 0.09% | $10.9M | 529.4K | $20.53 | $27.67 | 34.8% up | 3 qtrs | No change |
| 74 | [Equillium Inc EQ](https://funkfolio.com/stock/EQ) | — | 0.09% | $9.9M | 3.1M | $3.20 | $1.21 | 62.2% down | 2 qtrs | No change |
| 75 | [Macrogenics Inc MGNX](https://funkfolio.com/stock/MGNX) | — | 0.08% | $8.6M | 1.86M | $4.62 | $2.05 | 55.6% down | 2 qtrs | No change |
| 76 | Perceptive Cap Solutions no ticker on file | — | 0.07% | $8.2M | 750K | $10.88 | — | — | 9+ qtrs | No change |
| 77 | [Adicet Bio Inc ACET](https://funkfolio.com/stock/ACET) | — | 0.07% | $8.1M | 932.62K | $8.64 | $2.78 | 67.8% down | 9+ qtrs | ▼ Reduced 21% |
| 78 | Newamsterdam Pharma Co NV-27 no ticker on file · WTS | — | 0.06% | $7.1M | 333.33K | $21.37 | — | — | 9+ qtrs | No change |
| 79 | [Corvus Pharmaceuticals Inc CRVS](https://funkfolio.com/stock/CRVS) | — | 0.06% | $6.7M | 450K | $14.94 | $10.17 | 31.9% down | 2 qtrs | No change |
| 80 | [Rani Therapeutics Holdings-A RANI](https://funkfolio.com/stock/RANI) | — | 0.06% | $6.5M | 8.5M | $0.7604 | $0.5594 | 26.4% down | 3 qtrs | No change |
| 81 | [Jatt II Acquisition Corp JATT](https://funkfolio.com/stock/JATT) | — | 0.05% | $5.7M | 500K | $11.36 | $10.20 | 10.2% down | 1 qtr | New |
| 82 | [Amanat Acquisition Corp AMAN](https://funkfolio.com/stock/AMAN) | — | 0.03% | $3.8M | 375K | $10.16 | $10.09 | 0.7% down | 1 qtr | New |
| 83 | [Werewolf Therapeutics Inc HOWL](https://funkfolio.com/stock/HOWL) | — | 0.01% | $859.3K | 2.39M | $0.3599 | $1.05 | 191.7% up | 9+ qtrs | ▼ Reduced 64% |
| 84 | [Palatin Technologies Inc PTN](https://funkfolio.com/stock/PTN) | — | 0.01% | $670.3K | 62.12K | $10.79 | $5.36 | 50.3% down | 3 qtrs | ▼ Reduced 11% |

### Peter Kolchinsky latest buys (Q2 2026)

- [PBLS](https://funkfolio.com/stock/PBLS) New $791.9M
- [COAG](https://funkfolio.com/stock/COAG) New $286.8M
- [ABVX](https://funkfolio.com/stock/ABVX) New $150.9M
- [ORKA](https://funkfolio.com/stock/ORKA) New $148M
- [ARTV](https://funkfolio.com/stock/ARTV) ▲ Added 82% $78.6M
- [NTLA](https://funkfolio.com/stock/NTLA) New $76.6M
- [DFTX](https://funkfolio.com/stock/DFTX) New $70.6M
- [SANA](https://funkfolio.com/stock/SANA) New $65.4M
- [PRLD](https://funkfolio.com/stock/PRLD) New $34.5M
- [ACRS](https://funkfolio.com/stock/ACRS) ▲ Added 87% $31.3M

### Peter Kolchinsky latest sells (Q2 2026)

- [DNTH](https://funkfolio.com/stock/DNTH) Sold $219.2M
- Nuvalent Inc ▼ Reduced 51% $159M
- [PRAX](https://funkfolio.com/stock/PRAX) Sold $120.4M
- [SRPT](https://funkfolio.com/stock/SRPT) Sold $84.9M
- [EWTX](https://funkfolio.com/stock/EWTX) ▼ Reduced 20% $82.7M
- [SYRE](https://funkfolio.com/stock/SYRE) Sold $81.8M
- [VOR](https://funkfolio.com/stock/VOR) ▼ Reduced 56% $55.3M
- [FULC](https://funkfolio.com/stock/FULC) Sold $46.4M
- [OLMA](https://funkfolio.com/stock/OLMA) Sold $38.8M
- [DSGN](https://funkfolio.com/stock/DSGN) Sold $31.6M

[Every buy and sell in Peter Kolchinsky's Q2 2026 13F →](https://funkfolio.com/gurus/activity?investor=peter-kolchinsky)

### By sector

Peter Kolchinsky portfolio by sector, Q2 2026

| Sector | Share of portfolio | Value | Positions |
| --- | --- | --- | --- |
| [Health Care](https://funkfolio.com/companies?sector=health-care) | 42.6% | $4.9B | 8 |
| [Technology](https://funkfolio.com/companies?sector=technology) | 0.09% | $10.9M | 1 |
| No sector on file | 57.3% | $6.6B | 75 |

8 quarterly filings on file for RA Capital Management, back to Q3 2024: reported value, position counts, and every buy and sell quarter by quarter.

[Filing history →](https://funkfolio.com/gurus/peter-kolchinsky/history) [All Q2 2026 13F filings →](https://funkfolio.com/gurus/quarter/2026-q2)

### Questions about Peter Kolchinsky's portfolio

**What stocks does Peter Kolchinsky own?**

According to RA Capital Management's 13F filing for Q2 2026, the largest of its 84 US-listed positions are ASND (23.8%), PBLS (6.9%), RYTM (6.4%), PCVX (5.8%) and SION (3.8%). A 13F shows long positions only, as of the quarter's end.

**What is Peter Kolchinsky's largest holding?**

ASND (Ascendis Pharma A/S), worth $2.7B at the end of Q2 2026, or 23.8% of the $11.5B RA Capital Management reported.

**What did Peter Kolchinsky buy last quarter?**

In Q2 2026, compared with the filing for Q1 2026, the largest purchases were PBLS (new position, $791.9M), COAG (new position, $286.8M), ABVX (new position, $150.9M), ORKA (new position, $148M) and ARTV (added, $78.6M).

**What did Peter Kolchinsky sell last quarter?**

In Q2 2026 the largest sales were DNTH (sold out, $219.2M), Nuvalent Inc (reduced, $159M), PRAX (sold out, $120.4M), SRPT (sold out, $84.9M) and EWTX (reduced, $82.7M), against the filing for Q1 2026.

**How much is Peter Kolchinsky's portfolio worth?**

RA Capital Management reported $11.5B in 84 US-listed positions for Q2 2026, valued at the quarter's end and filed on August 14, 2026. That is the 13F portfolio only: no cash, short positions or most shares listed outside the US.

**When does Peter Kolchinsky file the next 13F?**

The 13F for Q3 2026, the quarter ending September 30, 2026, was due by November 16, 2026: 45 days after the quarter ends, or the next business day. The latest filing on file here is for Q2 2026, filed on August 14, 2026.

**Which sectors does Peter Kolchinsky own?**

Health Care 42.6%, Technology 0.1% of the reported portfolio, with 57.3% in securities that have no sector on file here (funds, smaller companies, positions without a ticker).

**How long has Peter Kolchinsky held these stocks?**

Counting consecutive quarterly filings up to Q2 2026: ASND 9+, PBLS 1, RYTM 9+, PCVX 9+, SION 6, TYRA 9+. “9+” means the position is in every filing looked at, so it may go back further.

### Learn

- [What a 13F filing is](https://funkfolio.com/learn/superinvestors/what-is-a-13f)
- [How to read a superinvestor's portfolio](https://funkfolio.com/learn/superinvestors/how-to-read-a-13f-portfolio)
- [New, added, reduced, sold: reading 13F changes](https://funkfolio.com/learn/superinvestors/13f-changes-explained)
- [All superinvestor guides](https://funkfolio.com/learn/superinvestors)

### Cite this page

Funkfolio, “Peter Kolchinsky portfolio: RA Capital Management 13F holdings (Q2 2026)”, data as of 14 August 2026. https://funkfolio.com/gurus/peter-kolchinsky

Underlying data: SEC EDGAR, Form 13F-HR of RA Capital Management (CIK 1346824) for the period ending June 30, 2026.

Source: SEC EDGAR, Form 13F-HR for RA Capital Management (CIK 1346824), period ending Jun 30, 2026, filed Aug 14, 2026. “Last quarter” compares share counts with the filing for Mar 31, 2026. “Reported price” is the position's reported value divided by its shares — the price the filing implies for the period end. “Price now” is from Yahoo Finance and can be delayed 15 minutes or more; “since period end” sets the two side by side and is left blank where the reported price falls outside the stock's 52-week range, which points to a share split since. A split small enough to stay inside that range is not caught, and dividends are not counted. Sectors are those of the ranked companies on this site; funds, smaller companies and positions without a ticker have none. “Held” counts consecutive quarterly filings the position appears in, out of the 9 looked at. A buy or sell is sized as the shares moved at the price the filing implies; a position sold out at its value in the previous filing. Filings can be 45 days old when published; this is not a live portfolio and not advice.
